Demy

BioFuture™ Conference Brings Together Stakeholders In Transformative Healthcare Summit

Retrieved on: 
Thursday, November 17, 2022
Biotechnology, Practice Management, Telemedicine, Virtual Medicine, Pharmaceutical, Health, Artificial Intelligence, Health Technology, Technology, AI, City, Lotte New York Palace Hotel, Health, Demy, Therapy, Big data, Alzheimer's disease, Stanford University, Eli Lilly, Virtual reality, Neuroscientist, Virtual, Johnson & Johnson, Learning, VR, Biotechnology, Pharmaceutical industry, Management

Held at the Lotte New York Palace from November 7-9 and the following week virtually, the event brought together healthcare and biotechnology leaders, investors, sector stakeholders, and bleeding-edge disruptors who are reimagining therapeutics.

Key Points: 
  • Held at the Lotte New York Palace from November 7-9 and the following week virtually, the event brought together healthcare and biotechnology leaders, investors, sector stakeholders, and bleeding-edge disruptors who are reimagining therapeutics.
  • The 2022 program featured insights from top biotech, digital medicine, virtual reality, and healthcare executives across a broad spectrum of areas of expertise.
  • BioFuture featured more than 100 speakers who examined the exciting convergence between rapidly evolving fields, including biopharma, digital medicine, big data, AI, VR, healthcare systems, and more.
  • Its unique events facilitate networking on a global scale, including Biotech Showcase, BioFuture, Biotech CEO Summit Europe, Biotech CEO Summit, and Demy-Colton Virtual Salons.

Over 550 Attendees Expected at BioFuture™ Conference in New York City

Retrieved on: 
Tuesday, October 18, 2022
Biotechnology, Practice Management, Telemedicine, Virtual Medicine, Pharmaceutical, Health, Artificial Intelligence, Health Technology, Technology, Linda, Reverse-path forwarding, Doctor of Philosophy, Therapy, List of national museums, Machine learning, Director, Demy, Health, Twitter, Multimedia, William A. Haseltine, Learning, Industry, Biological anthropology, AI, Big data, Partnership, Ecosystem, Smithsonian Institution, Lotte New York Palace Hotel, National Museum of Natural History, Natural history, Biotechnology, Pharmaceutical industry, Medical device, Management, MD

This future-focused in-person event will take place at Lotte New York Palace from November 7-9, 2022.

Key Points: 
  • This future-focused in-person event will take place at Lotte New York Palace from November 7-9, 2022.
  • View the full release here: https://www.businesswire.com/news/home/20221018005935/en/
    BioFuture features multiple tracks of plenary sessions, presenting companies , workshops, networking, and an opportunity to schedule one-to-one meetings.
  • Attendees will gain insights into the sectors and innovations driving breakthrough therapeutics and contribute to candid discussions challenging conventional wisdom.
  • Our mission for BioFuture is to help expand this ecosystem of stakeholders to better shape the future of healthcare and digital health.

Demy-Colton Announces Launch of BioFuture™ Conference

Retrieved on: 
Thursday, September 15, 2022
Data Management, Biotechnology, Technology, Other Health, Health, Pharmaceutical, Other Science, Research, Software, Artificial Intelligence, Science, Linda, Eli Lilly and Company, Therapy, Demy, Machine learning, Twitter, Lotte New York Palace Hotel, Learning, Industry, Patient, Big data, CEO, Duke University, Ecosystem, Stanford University, Heart, Multimedia, AI, Biotechnology, Pharmaceutical industry, Google

Demy-Colton , a leader in connecting life science and digital health executives, today announced the second year launch of BioFuture , a conference convening healthcare thinkers, top investors, stakeholders, and cutting-edge disruptors who are reimagining the future of therapeutics.

Key Points: 
  • Demy-Colton , a leader in connecting life science and digital health executives, today announced the second year launch of BioFuture , a conference convening healthcare thinkers, top investors, stakeholders, and cutting-edge disruptors who are reimagining the future of therapeutics.
  • BioFuture will also offer a virtual partnering option from November 14-16, 2022, including access to the events recorded content.
  • BioFuture serves as a platform for pioneers, innovators, and investors to shape and transform the future of therapeutics.
  • For more information about BioFuture, please visit www.biofuture.com or follow #BioFuture2022 on Twitter for the latest updates and discussions.

Demy-Colton Announces Upcoming Virtual Salon Series Featuring Exclusive Fireside Chats with JP Morgan's Mike Gaito and FDA’s Amy Abernethy

Retrieved on: 
Wednesday, September 9, 2020
Oncology, Health, Genetics, Other Science, Science, Pharmaceutical, Biotechnology, Musicians, Greek singers, Singers, Fireside, Demy, Salon, Digital health

Demy-Colton , a leader in connecting life science and digital health executives, announced today several new installments to its Virtual Salon Series , including exclusive fireside chats with Mike Gaito, Head of Global Healthcare Banking, JP Morgan and Amy Abernethy, Principal Deputy Commissioner, US Food & Drug Administration.

Key Points: 
  • Demy-Colton , a leader in connecting life science and digital health executives, announced today several new installments to its Virtual Salon Series , including exclusive fireside chats with Mike Gaito, Head of Global Healthcare Banking, JP Morgan and Amy Abernethy, Principal Deputy Commissioner, US Food & Drug Administration.
  • The Demy-Colton Virtual Salon Series brings cutting-edge insights from key opinion leaders in the life sciences and digital health industries.
  • The webinar-based series includes discussion tracks on: BioFuture, Meet the Disruptors, NYC Biotech Spotlight, and Biotech CEO Summit Dialogue series.
  • Since its launch in May, the Virtual Salon Series has attracted thousands of viewers from the life sciences and investor communities.

Demy-Colton Launches Virtual Salon Series to Bring the Latest Insights in Life Sciences & Digital Health

Retrieved on: 
Monday, May 18, 2020
Technology, Managed care, Medical devices, General Health, Infectious diseases, Science, Genetics, Clinical trials, Biotechnology, Health, Other Science, Research, Software, Pharmaceutical, Data management, Practice Management, Oncology, Musicians, Greek singers, Singers, Demy, 1

Demy-Colton , a leader in connecting life science and digital health executives, announced today the launch of the Demy-Colton Virtual Salon Series, to bring cutting-edge insights from key opinion leaders in the life sciences and digital health industry.

Key Points: 
  • Demy-Colton , a leader in connecting life science and digital health executives, announced today the launch of the Demy-Colton Virtual Salon Series, to bring cutting-edge insights from key opinion leaders in the life sciences and digital health industry.
  • The featured virtual salon series tracks include: BioFuture, Meet the Disruptors, NYC Biotech Spotlight, COVID-19 Updates, and Biotech CEO Summit series.
  • The discussion topic is The Future of Health Care: Innovation, Change and Urgency.
  • The webinar sessions are complimentary and open to anyone in the industry and will provide an opportunity to engage directly with leaders in life sciences and digital health, as well as Demy-Colton.

Genprex to Present at Biotech Showcase™ 2020 in San Francisco

Retrieved on: 
Monday, January 6, 2020
Oncology, Health, Genetics, Research, Science, Pharmaceutical, Biotechnology, Union Square, San Francisco, Hilton San Francisco Union Square, Demy

Genprex, Inc. (Genprex or the Company) (NASDAQ: GNPX ), a clinical-stage gene therapy company utilizing a unique, nonviral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced it will attend and present at the Biotech Showcase 2020 to be held January 1315, 2020 at the Hilton San Francisco Union Square in San Francisco.

Key Points: 
  • Genprex, Inc. (Genprex or the Company) (NASDAQ: GNPX ), a clinical-stage gene therapy company utilizing a unique, nonviral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced it will attend and present at the Biotech Showcase 2020 to be held January 1315, 2020 at the Hilton San Francisco Union Square in San Francisco.
  • Genprex will present at the Biotech Showcase 2020 as follows:
    Location: Hilton San Francisco Union Square Hotel, 333 O'Farrell Street, San Francisco
    Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities.
  • The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.
  • We are delighted that Genprex will be presenting at Biotech Showcase this year, said Sara Demy, CEO of Demy-Colton.

Kenzie Academy Raises $7.8 Million for Accessible Tech Training in Middle America

Retrieved on: 
Monday, September 30, 2019
Kenzie, Demy

INDIANAPOLIS, Sept. 30, 2019 /PRNewswire/ -- Kenzie Aca demy , an Indianapolis-based college alternative providing job-focused technology training to middle America, today announced $7.8 million in Series A funding, led by ReThink Education.

Key Points: 
  • INDIANAPOLIS, Sept. 30, 2019 /PRNewswire/ -- Kenzie Aca demy , an Indianapolis-based college alternative providing job-focused technology training to middle America, today announced $7.8 million in Series A funding, led by ReThink Education.
  • "There is a massive amount of untapped tech talent outside of Silicon Valley and NYC.
  • Kenzie is identifying this talent to fill the millions of jobs available, training workforce-ready skills and connecting students almost immediately with top employers," said Chok Ooi, Co-founder and CEO of Kenzie Academy.
  • Kenzie Academy is a college alternative that creates jobs for tomorrow's economy by providing technology training to anyone looking to accelerate their career.